MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness
Not Applicable
Completed
- Conditions
- Lung CancerGI CancerMajor DepressionSchizophreniaCancerBipolar DisorderBreast CancerHead and Neck Cancer
- Interventions
- Other: Proactive Psychiatry Consultation (PPC)
- First Posted Date
- 2015-11-03
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02594696
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age
Phase 1
Completed
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2015-10-21
- Last Posted Date
- 2022-08-24
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT02582359
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN
Phase 1
Completed
- Conditions
- Thermal Imaging, Neonatal Pneumonia, Tachypnea
- Interventions
- Device: Thermal Imaging
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT02570828
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Noninvasive Physiologic Sensors to Assess Depression
Completed
- Conditions
- DepressionMajor Depressive Disorder
- Interventions
- Other: Physiological SensorsOther: Sleep Monitoring DeviceOther: Vocal MonitoringOther: Mobile Phone
- First Posted Date
- 2015-10-06
- Last Posted Date
- 2020-02-25
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT02568865
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
A Pilot Randomized Controlled Trial of Financial Incentives, Text Messaging, and Usual Care for Homeless Smokers
Not Applicable
Completed
- Conditions
- Smoking
- Interventions
- Behavioral: In-person smoking cessation counselingBehavioral: Text messages to support smoking abstinenceBehavioral: Contingent financial rewards for smoking abstinence
- First Posted Date
- 2015-10-01
- Last Posted Date
- 2017-07-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 83
- Registration Number
- NCT02565381
- Locations
- 🇺🇸
Boston Health Care for the Homeless Program, Boston, Massachusetts, United States
Neurobiological Underpinnings of Placebo Response in Depression
Phase 4
Completed
- Conditions
- Depression
- Interventions
- Drug: Welbutrin XLDrug: Placebo
- First Posted Date
- 2015-09-29
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 73
- Registration Number
- NCT02562430
- Locations
- 🇺🇸
Depression Clinical and Research Program at Massachusetts General Hospital, Boston, Massachusetts, United States
Resiliency Training for Adolescents With Craniofacial Conditions and Their Caregivers
Not Applicable
Withdrawn
- Conditions
- Craniofacial Abnormalities
- Interventions
- Behavioral: SMART-3RP
- First Posted Date
- 2015-09-29
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT02562339
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML
Phase 2
Completed
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT02560025
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD
Phase 2
Completed
- Conditions
- Attention Deficit/Hyperactivity DisorderADHD
- Interventions
- Drug: L-Threonic Acid Magnesium Salt (L-TAMS)
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02558790
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
Completed
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Interventions
- Drug: [18F] GE-180
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 86
- Registration Number
- NCT02559869
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States